Literature DB >> 15157821

Epidemiology of IBD during the twentieth century: an integrated view.

Vibeke Binder1.   

Abstract

Current incidence figures on ulcerative colitis and Crohn's disease--presented in a recent multicenter study in Europe--are given, and differences in the frequency and clinical appearances of the two conditions are discussed. Trends in the frequency and clinical appearance of inflammatory bowel disease during the twentieth century are summarized, as well as the differences over time and from place to place. Correlations between age, sex, localization of disease and clinical symptoms are given. Risk of progression to more extensive disease in patients with proctitis is shown. Incidences of inflammatory bowel disease in childhood and among migrated ethnic groups are discussed. Survival and cancer risk among patients with ulcerative colitis and Crohn's disease are shown from long-term clinical epidemiological studies of well-defined patient groups. Trends in these important prognostic parameters over time are shown, as well as factors influencing prognosis of the diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15157821     DOI: 10.1016/j.bpg.2003.12.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  34 in total

Review 1.  A meta-analysis on the influence of inflammatory bowel disease on pregnancy.

Authors:  J Cornish; E Tan; J Teare; T G Teoh; R Rai; S K Clark; P P Tekkis
Journal:  Gut       Date:  2006-12-21       Impact factor: 23.059

2.  Polymeric formula has direct anti-inflammatory effects on enterocytes in an in vitro model of intestinal inflammation.

Authors:  Naomi S H de Jong; Steven T Leach; Andrew S Day
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

3.  Role of major histocompatibility complex class I-related molecules A*A5.1 allele in ulcerative colitis in Chinese patients.

Authors:  Min Lü; Bing Xia; Liuqing Ge; Yi Li; Jie Zhao; Fan Chen; Feng Zhou; Xiaolian Zhang; Jinquan Tan
Journal:  Immunology       Date:  2008-11-07       Impact factor: 7.397

Review 4.  Inflammatory bowel disease in pregnancy.

Authors:  Charles B Ferguson; Samina Mahsud-Dornan; R Neil Patterson
Journal:  BMJ       Date:  2008-07-03

5.  Evaluation of anti-colitic effect of lactic acid bacteria in mice by cDNA microarray analysis.

Authors:  Hoyong Lee; Young-Tae Ahn; Jung-Hee Lee; Chul-Sung Huh; Dong-Hyun Kim
Journal:  Inflammation       Date:  2009-12       Impact factor: 4.092

6.  What made Canada become a country with the highest incidence of inflammatory bowel disease: could sucralose be the culprit?

Authors:  Xiaofa Qin
Journal:  Can J Gastroenterol       Date:  2011-09       Impact factor: 3.522

7.  Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice.

Authors:  In-Ah Lee; Eun-Ah Bae; Yang-Jin Hyun; Dong-Hyun Kim
Journal:  J Inflamm (Lond)       Date:  2010-02-01       Impact factor: 4.981

8.  Lancemaside A ameliorates colitis by inhibiting NF-kappaB activation in TNBS-induced colitis mice.

Authors:  Eun-Ha Joh; In-Ah Lee; Sang-Jun Han; Sunju Chae; Dong-Hyun Kim
Journal:  Int J Colorectal Dis       Date:  2009-12-03       Impact factor: 2.571

9.  Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis.

Authors:  Jung-Hee Lee; Bomi Lee; Hye-Sung Lee; Eun-Ah Bae; Hoyong Lee; Young-Tae Ahn; Kwang-Sei Lim; Chul-Sung Huh; Dong-Hyun Kim
Journal:  Int J Colorectal Dis       Date:  2008-12-03       Impact factor: 2.571

10.  Infliximab in ulcerative colitis.

Authors:  Avi Levin; Oren Shibolet
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.